Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and
the resulting coronavirus disease 2019 (Covid-19) have afflicted tens of millions of people in …

Background BNT162b2 is a lipid nanoparticle–formulated, nucleoside-modified RNA vaccine
encoding a prefusion-stabilized, membrane-anchored severe acute respiratory syndrome …

Background Therapies to interrupt the progression of early coronavirus disease 2019 (Covid-19)
remain elusive. Among them, convalescent plasma administered to hospitalized …

Background Respiratory syncytial virus (RSV) infection causes considerable illness in older
adults. The efficacy and safety of an investigational bivalent RSV prefusion F protein–based (…

Background Whether vaccination during pregnancy could reduce the burden of respiratory
syncytial virus (RSV)–associated lower respiratory tract illness in newborns and infants is …

Background Coronavirus-like particles (CoVLP) that are produced in plants and display the
prefusion spike glycoprotein of the original strain of severe acute respiratory syndrome …

Background Respiratory syncytial virus (RSV) is the dominant cause of severe lower respiratory
tract infection in infants, with the most severe cases concentrated among younger infants…

Background BNT162b2 is a lipid nanoparticle-formulated, nucleoside-modified RNA vaccine
encoding a prefusion-stabilized, membrane-anchored SARS-CoV-2 full-length spike protein…

vol. 105 número2 Gastrostomía endoscópica percutánea en pacientes con daño
neurológico grave: 15 años de práctica Displasia diastrófica: un raro tipo de …

Background Respiratory syncytial virus (RSV) can cause substantial morbidity and mortality
among older adults. An mRNA-based RSV vaccine, mRNA-1345, encoding the stabilized …